Lung

Lung & Prostate Cancer Clinical Research Fellowship — McMaster University

1–2 year Radiation Oncology fellowship at Juravinski Cancer Centre (McMaster University) focused on advanced lung and prostate radiotherapy (IMRT, VMAT, SBRT) plus translational/early-phase clinical trial and biomarker research. Start date July 1, 2026. 

Eligibility Criteria:

  • Eligible for College of Physicians and Surgeons of Ontario (CPSO) license; foreign graduates may apply if able to obtain educational license, work permit, and visa.

  • Prior formal Radiation Oncology residency training.

  • Canadian citizens/permanent residents considered first (citizenship disclosure statement required).

  • Complete application with online fellowship form, CV, three reference letters (one from Residency Program Director), cover letter with learning goals and proposed project, and medical school transcripts. 

Funding Details:

  • 1–2 year clinical/clinical-research fellowship; funding terms not specified in the call.

  • Training includes IMRT/VMAT/SBRT, participation in translational and early-phase trials, and biomarker studies; opportunities to collaborate with Ontario Clinical Oncology Group (OCOG).

  • Academic options: one-year fellows may enroll in the Graduate Diploma in Clinical Epidemiology; two-year fellows may pursue a Master’s (Health Research Methodology, Health Policy, Health Science Education, or Medical Sciences) and can explore the Clinician Investigator Program. 

Deadline:

  • Fellowship available July 1, 2026. 

Where to Go for Further Information: